Literature DB >> 12351383

Wiskott-Aldrich syndrome in a female.

Maxim I Lutskiy1, Yoji Sasahara, Dianne M Kenney, Fred S Rosen, Eileen Remold-O'Donnell.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked disease characterized by thrombocytopenia, eczema, and various degrees of immune deficiency. Carriers of mutated WASP have nonrandom X chromosome inactivation in their blood cells and are disease-free. We report data on a 14-month-old girl with a history of WAS in her family who presented with thrombocytopenia, small platelets, and immunologic dysfunction. Sequencing of the WASP gene showed that the patient was heterozygous for the splice site mutation previously found in one of her relatives with WAS. Sequencing of all WASP exons revealed no other mutation. Levels of WASP in blood mononuclear cells were 60% of normal. Flow cytometry after intracellular staining of peripheral blood mononuclear cells with WASP monoclonal antibody revealed both WASP(bright) and WASP(dim) populations. X chromosome inactivation in the patient's blood cells was found to be random, demonstrating that both maternal and paternal active X chromosomes are present. These findings indicate that the female patient has a defect in the mechanisms that lead in disease-free WAS carriers to preferential survival/proliferation of cells bearing the active wild-type X chromosome. Whereas the patient's lymphocytes are skewed toward WASP(bright) cells, about 65% of her monocytes and the majority of her B cells (CD19(+)) are WASP(dim). Her naive T cells (CD3(+)CD45RA(+)) include WASP(bright) and WASP(dim) populations, but her memory T cells (CD3(+)CD45RA(-)) are all WASP(bright). After activation in vitro of T cells, all cells exhibited CD3(+)CD45RA(-) phenotype and most were WASP(bright) with active paternal (wild-type) X chromosome, suggesting selection against the mutated WASP allele during terminal T-cell maturation/differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351383     DOI: 10.1182/blood-2002-02-0388

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  A novel Wiskott-Aldrich syndrome protein (WASP) complex mutation identified in a WAS patient results in an aberrant product at the C-terminus from two transcripts with unusual polyA signals.

Authors:  Nuria Andreu; Maricruz García-Rodríguez; Victor Volpini; Cecilia Frecha; Ignacio J Molina; Gumersindo Fontan; Cristina Fillat
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

Review 2.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

Review 3.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 4.  WASP: a key immunological multitasker.

Authors:  Adrian J Thrasher; Siobhan O Burns
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

5.  Targeted RNAseq Improves Clinical Diagnosis of Very Early-Onset Pediatric Immune Dysregulation.

Authors:  Kiera Berger; Dalia Arafat; Shanmuganathan Chandrakasan; Scott B Snapper; Greg Gibson
Journal:  J Pers Med       Date:  2022-06-01

6.  DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory.

Authors:  Teresa Lambe; Greg Crawford; Andy L Johnson; Tanya L Crockford; Tiphaine Bouriez-Jones; Aisling M Smyth; Trung H M Pham; Qian Zhang; Alexandra F Freeman; Jason G Cyster; Helen C Su; Richard J Cornall
Journal:  Eur J Immunol       Date:  2011-11-10       Impact factor: 5.532

7.  A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP.

Authors:  Gaetana Lanzi; Daniele Moratto; Donatella Vairo; Stefania Masneri; Ottavia Delmonte; Tiziana Paganini; Silvia Parolini; Giovanna Tabellini; Cinzia Mazza; Gianfranco Savoldi; Davide Montin; Silvana Martino; Pierangelo Tovo; Itai M Pessach; Michel J Massaad; Narayanaswamy Ramesh; Fulvio Porta; Alessandro Plebani; Luigi D Notarangelo; Raif S Geha; Silvia Giliani
Journal:  J Exp Med       Date:  2012-01-09       Impact factor: 14.307

Review 8.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

Review 9.  Whole-exome sequencing for detecting inborn errors of immunity: overview and perspectives.

Authors:  Barbara Bosch; Yuval Itan; Isabelle Meyts
Journal:  F1000Res       Date:  2017-11-28

10.  Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome.

Authors:  Maxim I Lutskiy; Jun Y Park; Susanna K Remold; Eileen Remold-O'Donnell
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.